Is stereotactic body radiotherapy an effective treatment in metastatic lung cancer with oligoprogressive disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is stereotactic body radiotherapy an effective treatment in metastatic lung cancer with oligoprogressive disease?

Published:2023-03-04 Issue:3 Volume:62 Page:298-304
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Aquilano Michele¹^ORCID,Loi Mauro²,Visani Luca²,Livi Lorenzo³,Nuyttens Joost J.⁴

Affiliation:

1. Radiation Oncology, Mater Olbia Hospital, Olbia, Italy

2. Department of Radiation Oncology, University of Florence, Florence, Italy

3. Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy

4. Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2186187

Reference39 articles.

1. Lung Cancer: Epidemiology, Etiology, and Prevention

2. Cancer statistics, 2015

3. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

4. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

5. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP